European Journal of Hospital Pharmacy

Papers
(The median citation count of European Journal of Hospital Pharmacy is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?60
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy17
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease14
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients13
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years12
Advanced therapy medicinal products12
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations11
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent11
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study11
Antithrombotic stewardship: whether to stop anticoagulation after atrial fibrillation ablation11
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings11
Is standard induction with mirikizumab sufficient in refractory ulcerative colitis in real-world practice?9
Empowering European hospital pharmacists in the face of heart failure9
Impact of CYP2C19 genotyping on clopidogrel therapy adjustments in patients with stroke or TIA9
EJHP’s impact factor moves on up8
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze7
The threatened medicines information pharmacist!7
Expanded expiry dates: a regulatory opportunity for Europe7
Correspondence on “Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements7
Hypoglycaemic coma induced by a falsified semaglutide product: a case report7
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology7
Drug–drug interactions in adjuvant and neoadjuvant breast cancer therapy6
Business continuity plans for hospital pharmacies: a Delphi consensus6
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts6
177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods6
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey6
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report6
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report6
Optimisation of the quality of care for patients with severe asthma: ASfarMA project6
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings6
The end of an era!6
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care5
Thoughts on the shortage of vinflunine: could we have done more?5
Challenges and opportunities for hospital pharmacists in the management of gene and cell therapies5
Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipi5
Beta-lactam allergy in patients: an antibiotic stewardship challenge5
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report5
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients5
Response to: Correspondence on ‘Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake5
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations5
EMA guidance for industry to prevent and mitigate medicine shortages5
Pharmaceutical validation of peripherally inserted central catheters: four years of implementation5
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis4
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C4
Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements4
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach4
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies4
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness4
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab4
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 20234
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time4
Medicinal mushrooms and chemotherapy: therapeutic synergy or hidden risk?4
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review4
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy4
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report4
Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review4
Drug-induced acute generalised exanthematous pustulosis: insights from FAERS data on a rare but severe cutaneous adverse reaction4
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-193
The future of pharmacy is already here: can we afford not to invest? Reflections from the seventh EAHP Synergy Certification Course 2025 in Bratislava3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology3
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management3
Penicillin allergy that persisted after 66 years: case report3
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports3
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients3
Organisational impact of in vivo gene therapies at two French injection centres3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 20223
Update on the hospital pharmacist profile: from clinical practice to management3
Pharmacological resilience in the context of geopolitical tensions: a European perspective3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?3
Hypomagnesaemia with niraparib: the need for comprehensive adverse effect reporting in drug labelling3
Clinical trials3
Fully validated HPLC-UV detection method associated with colour variation control for evaluation of the stability of 5-fluorouracil chemotherapy polyolefin infusion bags at dose banding3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit3
Systematic review of independent pharmacist prescribing for the treatment of cardiometabolic factors in chronic non-communicable diseases3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing3
Capecitabine: guaranteed access in adjuvant treatment of breast cancer3
Infectious diseases and antimicrobial resistance3
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database3
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients3
Medication adherence interventions: where are we and where do we go?3
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey3
An antidote network in Spain, a tool to improve antidote availability in hospitals3
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags3
Digital health2
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?2
Study of therapeutic patient education practices in French renal transplantation centres2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy2
Liquid antimicrobials: a national analysis of critical shortages2
Implementation of pharmacists’ monitoring for intravenous drug compatibility2
Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis2
Medication-related problems in critical care survivors: a systematic review2
Capillary electrophoresis in parenteral nutrition control – validation of two analytical methods: Amino acids/glucose/glucose-1-phosphate and K/Na/Ca/Mg2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation2
Factors associated with potential drug–drug interactions in psychiatric inpatients2
European health data space proposal launched2
Pharmacist-led patient education improves medication self-management and adherence in chronic hepatitis D virus patients: insights from the EXPLAIN project2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia2
To maximise impact, hospital pharmacists need to increase visibility2
Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support syst2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 12
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin2
Patient safety culture and medication safety in European intensive care units: a focus group study2
Results of EAHP’s 2023 shortages survey2
Safeguarding antimicrobial medicines reserved for treating humans2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review2
Introduction to an online only issue2
Defining a new term: defensive hospital pharmacy practices2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins2
Association of acamprosate versus gabapentinoids with liver disease progression and alcohol-related admissions in patients with alcohol use disorder2
Looking back and looking forward2
Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials2
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?2
Home antibiotic therapy in elastomeric infusion pumps – past, present and future2
Using local clinical rules in a pharmacy service to detect risk prescriptions in older adult hospital inpatients: a proof-of-concept study2
Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach” by Protze2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp2
Evaluation of resources for effective decision-making about drug manipulation2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2
Comparison of the 22nd World Health Organization Model List of Essential Medicines with the explicit criteria for the treatment of chronicity in elderly patients2
Realising potential and addressing risk: a UK survey of adult hepatology pharmacy services2
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques2
When gravimetry is debated by sponsors of clinical studies2
The secret life of the surgical pharmacy in high risk periods2
Drug intoxication: a silent obstacle to organ donation2
Ceftaroline combination therapy for methicillin resistant coagulase negative Staphylococcus bacteraemia and endocarditis2
Public information on shortages in the EU/EEA: improvements made between 2018 and 20202
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals2
Unit dose drug dispensing systems in hospitals: a systematic review of medication error reduction and cost-effectiveness2
Comparison of adverse drug reactions of statins in China from 1989 to 20192
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation1
Mobile pharmacies of the Ukrainian chain ‘Apteka 9-1-1’: access to medicines during the war in Ukraine1
Hospital pharmacists’ first impressions on the revision of the General Pharmaceutical Legislation1
Artificial intelligence and innovation in hospital pharmacy: embracing opportunities1
A pilot study investigating the clinical and financial impact of a pharmacist discharge service in a hospital setting1
Physicochemical stability of bevacizumab biosimilar CT-P16 (Vegzelma) concentrate for solution stored in original vials after first opening1
Drug shortages: A critical challenge in the era of automated intravenous compounding1
Physicochemical stability of the nefopam in elastomeric device at 0.2 and 3.33 mg/mL1
Spice-drug interactions: a case report on the use of turmeric, curry and ginger in a renal transplant patient on tacrolimus1
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials1
Transition to adult services: the current and potential role of the UK hospital pharmacist1
Physical compatibility of ceftriaxone and cefepime in 0.45% sodium chloride, Ringer’s lactate solution, and Plasma-Lyte A1
Drug-related problems at the heart of cardiac surgery1
Retrospective service evaluation of clinical pharmacist involvement in a critical care COVID-19 rehabilitation clinic1
Paracetamol loading dose administration in children: a retrospective study1
Hospital pharmacy workforce1
Stability assessment and content determination test of oral liquid forms of beclomethasone dipropionate prepared in hospital pharmacy1
Feasibility study of the digital tool Max for the patient-provided medication list in the medication reconciliation process prior to hospitalisation: patient willingness and usability, time saved and 1
Ciclosporin-related posterior reversible encephalopathy syndrome in a paediatric haematopoietic stem cell transplant recipient1
Maintaining the stability of furosemide tablets during enteral feeding tube delivery using PVC and non-PVC tubes, in accordance with hospital protocols1
Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit1
Gender bias in biomedical research1
Factors influencing accuracy when preparing injectable drug concentrations in appliance with clinical practice: a norepinephrine case study1
Taking care of caregivers: enhancing proper medication management for palliative care children with polypharmacy1
Beyond the 5S methodology applied to healthcare management1
Comparison of sodium zirconium cyclosilicate and sodium polystyrene sulfonate in the treatment of acute hyperkalaemia1
Physicochemical stability of ready-to-administer mitomycin C solutions for intravesical instillation1
EAHP-EANM joint statement1
Maintaining appropriate stocks in an operating room pharmaceutical unit: risk mapping of the supply chain.1
Impact of patient-centred care and population health management on diabetes and hypertension outcomes1
Nine years’ experience of an educational programme for patients treated with oral anticoagulants in a cardiology department1
Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens1
Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique1
Contribution of hospital pharmacists to sustainable healthcare: a systematic review1
Clopidogrel-induced thrombotic microangiopathy: a case report1
EAHP sets out to future-proof the hospital pharmacy workforce1
Is peer review running out of steam?1
Extravasation of brentuximab vedotin, an antibody-drug conjugate, in a patient with anaplastic large cell lymphoma1
Prescribe less, ask more: the patient-centred pharmacology we need1
Identical but lethal: managing the LASA risk of plastic potassium chloride ampoules through organisational constraints1
Predicting unplanned hospital revisits among community-dwelling older adults: a dynamic cohort study1
Response to: Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approa1
Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey1
Correspondence on ‘COVID-19 vaccine triggered autoimmune hepatitis: case report’ by Mathewet al1
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness1
Scarce plasma, rising demand: why pharmacist-led immunoglobulin stewardship matters1
Performance evaluation of the HPLC diode array and evaporative light scattering detection for the implementation of dose-banded gemcitabine infusion bags1
Is one enough?1
Successful desensitisation to paclitaxel with omalizumab1
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK1
Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital1
EAHP general assembly updates position paper on clinical trials1
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions1
Manipulating prednisolone tablets for paediatric adjustments – dose accuracy and precision1
Addressing the at-home care needs of patients with multidrug-resistant bacteria: what should we do?1
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study1
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients1
Potential risk of non-arteritic anterior ischaemic optic neuropathy in semaglutide users: pharmacovigilance insights1
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials1
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study1
Enhancing depression management in older cancer patients: the pharmacist’s role1
The geriatric clinical pharmacist at the emergency department: a novel front-door transdisciplinary care model1
Optimising electronic health records for highly specialised hospital areas: a call for collaborative hospital pharmacist involvement1
Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainment1
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators1
A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration1
Fixed or weight-adjusted dose in immunotherapy?1
Ifosfamide-induced encephalopathy and concomitant use of netupitant/palonosetron in a patient with soft tissue sarcoma: a case report1
Thirty congresses: What a journey!1
Adverse drug reactions in paediatric age: analysis of spontaneous reports and reasons for under-reporting in a Local Health Unit in Veneto region1
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital1
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia1
Compatibility and physicochemical stability of ceftriaxone for injection admixed with pantoprazole sodium and ondansetron hydrochloride in different infusion solutions1
Performance and risks of ChatGPT used in drug information: comment1
Posaconazole therapeutic drug monitoring in haematologic malignancies: a persistent practice gap1
Impact of the use of a drug–drug interaction checker on pharmacist interventions involving well-known strong interactors1
Risk of exposure of patients’ family members to lenalidomide at home1
Medication reconciliation at patient admission in psychiatric setting: prioritisation tool to reduce medication errors (O-PsyConcil)1
Stability of clozapine tablets repackaged in dose administration aids using repackaging machines1
Polymyxin B-related neurotoxicity: a brief case report1
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions1
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews1
Losartan potassium liquid formulation for paediatric hospital use: development and stability evaluation1
Qualification and impact of a video-assisted control system in a chemotherapy compounding unit1
Exposure to potentially harmful excipients in neonates admitted to intensive care units using compounded medicines0
Enhancing pharmaceutical decision support system: evaluating antithrombotic-focused algorithms for addressing drug-related problems0
Critical role of persistence and adherence in multiple sclerosis treatment: the value of cladribine0
Adherence and persistence rates for antidiabetic treatments in type 2 diabetes: a real-world study in an Italian region0
Assessing health literacy in transplant patients to better tailor the content of their therapeutic education: an observational study0
Impact of pharmaceutical care on hospital readmissions for heart failure: a randomised trial0
Quality assurance standards and their use in the preparation of parenteral systemic anticancer therapy products in healthcare establishments: a scoping review0
Physicochemical stability of high-concentration cefuroxime aqueous injection reconstituted by a centralised intravenous additive service0
Safeguarding drug safety: addressing duplicates in pharmacovigilance reporting0
Evaluation of the impact of pharmacist-led educational intervention on knowledge and skills of cancer patients with totally implantable venous access port: a single-centre, non-randomised controlled s0
Severe immune-mediated hepatitis caused by sindilizumab combined with local radiotherapy: a case report0
Investigation of the hospital pharmacy profession in Europe0
Resolution rate of prescribing errors after advice from a specialised hospital pharmacist or a substitute hospital pharmacist: a retrospective cross-sectional study0
Importance of randomisation—a call to researchers0
Help EAHP assess and advance hospital pharmacy!0
Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide0
Spain takes over Presidency of the Council of the European Union0
RETRACTION—Specific features of rational pharmacotherapy in elderly patients0
Hospital pharmaceutical expenditure: a need to focus on an ‘obscure’ and growing component of pharmaceutical spending0
From bad to worse: the shortage of fibrinolytics0
The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure0
Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study0
Benznidazole-induced drug reaction with eosinophilia and systemic symptoms syndrome in a patient with human leucocyte antigen (HLA)-A*680
Limited sample stability of chenodeoxycholic acid in pharmaceutical quality control0
0.095004081726074